SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.54+3.2%Jan 9 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Abuckatatime who wrote (8011)9/29/1997 2:55:00 PM
From: Andrew H   of 32384
 
Greg and Henry--below is the relevant quote:

>>``The majority of the
higher dose drug-related adverse events consisted of reversible neutropenia (a reduction of white
blood cells) without infectious complications and elevation of serum triglycerides,'' Dr. Yocum said. <<

Because infectious complications and elevation of suerum triglycerides both follow the word WITHOUT, it seems clear to me that neutrophenia is the only problem identified and appears WITHOUT infectious complications and elevation of triglycerides.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News